🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

12572+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 12572 recruiting trials

Phase 4RecruitingNCT06420258

Deeper Intubation Make Effects on Cervical Esophageal ESD

👨‍⚕️ Wei Liang, MD, Fujian Provintial Hospital📍 1 site📅 Started Oct 2022View details ↗
NARecruitingNCT05657652

CAV Regimen for R/R Ph- B-ALL

🏥 The First Affiliated Hospital of Soochow University📍 1 site📅 Started Oct 2022View details ↗
NARecruitingNCT05067764

Efficacy of Aponeurectomy on the 2-year Recurrence Rate of Dupuytren's Disease

👨‍⚕️ Elias SAWAYA, MD, Institut Aquitain de la Main📍 2 sites📅 Started Sep 2022View details ↗
Enrolling by InvitationNCT05635747

A 90 Day Observational Study as an Extension to the Phase 3,Open Labeled Exploratory Study of RELiZORB

👨‍⚕️ Mark Puder, MD, PhD, Boston Children's Hospital📍 1 site📅 Started Sep 2022View details ↗
NARecruitingNCT05219110

Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection

👨‍⚕️ Stephen Freedman, MDCM, University of Calgary📍 26 sites📅 Started Sep 2022View details ↗
Phase 3RecruitingNCT05476939

Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0

👨‍⚕️ Jacques GRILL, MD, PhD, Gustave Roussy, Cancer Campus, Grand Paris📍 50 sites📅 Started Sep 2022View details ↗
NARecruitingNCT05523128

The Efficacy and Safety of ZS802 in Chinese Hemophilia A Patients.

👨‍⚕️ Lei Zhang, MD, Institute of Hematology & Blood Diseases Hospital, China📍 1 site📅 Started Sep 2022View details ↗
Phase 3RecruitingNCT06190782

Local Therapy for Oligometastatic ESCC Patients Treated With PD-1 Inhibitor

👨‍⚕️ Kuaile Zhao, MD, Fudan University📍 1 site📅 Started Sep 2022View details ↗
Phase 4RecruitingNCT05682131

South China Children Cancer Group - Relapsed-Acute Lymphoblastic Leukemia 2022 Protocol

👨‍⚕️ Xin Y Chen, Doctoral, Medical Ethics Committee of Sun Yat-sen Memorial Hospital of Sun Yat-sen University📍 1 site📅 Started Sep 2022View details ↗
Phase 3RecruitingNCT05503264

A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Satralizumab in Participants With Anti-N-methyl-D-aspartic Acid Receptor (NMDAR) or Anti-leucine-rich Glioma-inactivated 1 (LGI1) Encephalitis

👨‍⚕️ Clinical Trials, Hoffmann-La Roche📍 92 sites📅 Started Sep 2022View details ↗
RecruitingNCT06293560

Microphthalmia, Anophthalmia, and Coloboma Genetic Epidemiology in Children

🏥 Baylor College of Medicine📍 1 site📅 Started Sep 2022View details ↗
Phase 2, PHASE3RecruitingNCT05327114

Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

👨‍⚕️ Janssen Research & Development, LLC Clinical Trial, Janssen Research & Development, LLC📍 103 sites📅 Started Sep 2022View details ↗
Phase 2RecruitingNCT05365035

A Phase II Study of Cladribine and Low Dose Cytarabine in Combination With Venetoclax, Alternating With Azacitidine and Venetoclax, in Patients With Higher-risk Myeloproliferative Chronic Myelomonocytic Leukemia or Higher-risk Myelodysplastic Syndromes With Excess Blasts

👨‍⚕️ Guillermo Bravo, MD, M.D. Anderson Cancer Center📍 1 site📅 Started Sep 2022View details ↗
Phase 2, PHASE3RecruitingNCT05543616

A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children

👨‍⚕️ Pfizer CT.gov Call Center, Pfizer📍 134 sites📅 Started Sep 2022View details ↗
RecruitingNCT05502133

Identification of Acute Intermittent Porphyria Modifying Genes

👨‍⚕️ Robert J Desnick, Ph.D, MD, Icahn School of Medicine at Mount Sinai📍 1 site📅 Started Sep 2022View details ↗
Phase 1, PHASE2RecruitingNCT05039281

Atezolizumab and Cabozantinib for the Treatment of Recurrent Glioblastoma

👨‍⚕️ Shiao-Pei S Weathers, M.D. Anderson Cancer Center📍 1 site📅 Started Sep 2022View details ↗
Phase 2RecruitingNCT03083431

Oral Propranolol for Prevention of Threshold Retinopathy of Prematurity

👨‍⚕️ Dirk Bassler, M.D., University of Zurich📍 3 sites📅 Started Sep 2022View details ↗
RecruitingNCT06203093

Charcot-Marie-Tooth Disease (CMT) Biological Sample Collection for IPSC Generation and Biobanking

👨‍⚕️ Laura Andres-Martin, New York Stem Cell Foundation Research Institute📍 1 site📅 Started Sep 2022View details ↗
RecruitingNCT05858385

Predictive Study on Acute Radiation Induced Oral Mucositis in Nasopharyngeal Carcinoma Patients

🏥 Affiliated Cancer Hospital & Institute of Guangzhou Medical University📍 1 site📅 Started Sep 2022View details ↗
Phase 3RecruitingNCT05601700

Letrozole for Estrogen/Progesterone Receptor Positive Low-grade Serous Epithelial Ovarian Cancer (LEPRE Trial)

👨‍⚕️ Andrea DeCensi, MD, E.O.Ospedali Galliera📍 19 sites📅 Started Sep 2022View details ↗
← PreviousPage 453 of 629Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →